Covid-19 Impact on Global Retinal Biologics Market Size, Status and Forecast 2020-2026
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Retinal Biologics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Retinal Biologics industry.
Based on our recent survey, we have several different scenarios about the Retinal Biologics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Retinal Biologics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Biologics market in terms of revenue.
Players, stakeholders, and other participants in the global Retinal Biologics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Retinal Biologics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Retinal Biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Biologics market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Retinal Biologics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Retinal Biologics industry.
Based on our recent survey, we have several different scenarios about the Retinal Biologics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Retinal Biologics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Biologics market in terms of revenue.
Players, stakeholders, and other participants in the global Retinal Biologics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Retinal Biologics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Retinal Biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Biologics market.
The following players are covered in this report:
- Spark Therapeutics, Inc
- F. Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals, Inc
- AbbVie Inc
- Johnson & Johnson Services, Inc
- Amgen Inc
- ...
- Macular Degeneration
- Diabetic Retinopathy
- Diabetic Macular Edema
- Uveitis
- Others
- Hospitals
- Clinics
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Retinal Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Macular Degeneration
1.4.3 Diabetic Retinopathy
1.4.4 Diabetic Macular Edema
1.4.5 Uveitis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Retinal Biologics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Retinal Biologics Industry Impact
1.6.1 How the Covid-19 is Affecting the Retinal Biologics Industry
1.6.1.1 Retinal Biologics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Retinal Biologics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Retinal Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Retinal Biologics Market Perspective (2015-2026)
2.2 Retinal Biologics Growth Trends by Regions
2.2.1 Retinal Biologics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retinal Biologics Historic Market Share by Regions (2015-2020)
2.2.3 Retinal Biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retinal Biologics Market Growth Strategy
2.3.6 Primary Interviews with Key Retinal Biologics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Retinal Biologics Players by Market Size
3.1.1 Global Top Retinal Biologics Players by Revenue (2015-2020)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2015-2020)
3.1.3 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Biologics Market Concentration Ratio
3.2.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2019
3.3 Retinal Biologics Key Players Head office and Area Served
3.4 Key Players Retinal Biologics Product Solution and Service
3.5 Date of Enter into Retinal Biologics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Retinal Biologics Historic Market Size by Type (2015-2020)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2021-2026)
5 RETINAL BIOLOGICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Retinal Biologics Market Size by Application (2015-2020)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Retinal Biologics Market Size (2015-2020)
6.2 Retinal Biologics Key Players in North America (2019-2020)
6.3 North America Retinal Biologics Market Size by Type (2015-2020)
6.4 North America Retinal Biologics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Retinal Biologics Market Size (2015-2020)
7.2 Retinal Biologics Key Players in Europe (2019-2020)
7.3 Europe Retinal Biologics Market Size by Type (2015-2020)
7.4 Europe Retinal Biologics Market Size by Application (2015-2020)
8 CHINA
8.1 China Retinal Biologics Market Size (2015-2020)
8.2 Retinal Biologics Key Players in China (2019-2020)
8.3 China Retinal Biologics Market Size by Type (2015-2020)
8.4 China Retinal Biologics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Retinal Biologics Market Size (2015-2020)
9.2 Retinal Biologics Key Players in Japan (2019-2020)
9.3 Japan Retinal Biologics Market Size by Type (2015-2020)
9.4 Japan Retinal Biologics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Retinal Biologics Market Size (2015-2020)
10.2 Retinal Biologics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinal Biologics Market Size by Type (2015-2020)
10.4 Southeast Asia Retinal Biologics Market Size by Application (2015-2020)
11 INDIA
11.1 India Retinal Biologics Market Size (2015-2020)
11.2 Retinal Biologics Key Players in India (2019-2020)
11.3 India Retinal Biologics Market Size by Type (2015-2020)
11.4 India Retinal Biologics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Retinal Biologics Market Size (2015-2020)
12.2 Retinal Biologics Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinal Biologics Market Size by Type (2015-2020)
12.4 Central & South America Retinal Biologics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Spark Therapeutics, Inc
13.1.1 Spark Therapeutics, Inc Company Details
13.1.2 Spark Therapeutics, Inc Business Overview and Its Total Revenue
13.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
13.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2015-2020))
13.1.5 Spark Therapeutics, Inc Recent Development
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Details
13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
13.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Regeneron Pharmaceuticals, Inc
13.3.1 Regeneron Pharmaceuticals, Inc Company Details
13.3.2 Regeneron Pharmaceuticals, Inc Business Overview and Its Total Revenue
13.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
13.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2015-2020)
13.3.5 Regeneron Pharmaceuticals, Inc Recent Development
13.4 AbbVie Inc
13.4.1 AbbVie Inc Company Details
13.4.2 AbbVie Inc Business Overview and Its Total Revenue
13.4.3 AbbVie Inc Retinal Biologics Introduction
13.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2015-2020)
13.4.5 AbbVie Inc Recent Development
13.5 Johnson & Johnson Services, Inc
13.5.1 Johnson & Johnson Services, Inc Company Details
13.5.2 Johnson & Johnson Services, Inc Business Overview and Its Total Revenue
13.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
13.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2015-2020)
13.5.5 Johnson & Johnson Services, Inc Recent Development
13.6 Amgen Inc
13.6.1 Amgen Inc Company Details
13.6.2 Amgen Inc Business Overview and Its Total Revenue
13.6.3 Amgen Inc Retinal Biologics Introduction
13.6.4 Amgen Inc Revenue in Retinal Biologics Business (2015-2020)
13.6.5 Amgen Inc Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Retinal Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Macular Degeneration
1.4.3 Diabetic Retinopathy
1.4.4 Diabetic Macular Edema
1.4.5 Uveitis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Retinal Biologics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Retinal Biologics Industry Impact
1.6.1 How the Covid-19 is Affecting the Retinal Biologics Industry
1.6.1.1 Retinal Biologics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Retinal Biologics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Retinal Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Retinal Biologics Market Perspective (2015-2026)
2.2 Retinal Biologics Growth Trends by Regions
2.2.1 Retinal Biologics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retinal Biologics Historic Market Share by Regions (2015-2020)
2.2.3 Retinal Biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retinal Biologics Market Growth Strategy
2.3.6 Primary Interviews with Key Retinal Biologics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Retinal Biologics Players by Market Size
3.1.1 Global Top Retinal Biologics Players by Revenue (2015-2020)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2015-2020)
3.1.3 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Biologics Market Concentration Ratio
3.2.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2019
3.3 Retinal Biologics Key Players Head office and Area Served
3.4 Key Players Retinal Biologics Product Solution and Service
3.5 Date of Enter into Retinal Biologics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Retinal Biologics Historic Market Size by Type (2015-2020)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2021-2026)
5 RETINAL BIOLOGICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Retinal Biologics Market Size by Application (2015-2020)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Retinal Biologics Market Size (2015-2020)
6.2 Retinal Biologics Key Players in North America (2019-2020)
6.3 North America Retinal Biologics Market Size by Type (2015-2020)
6.4 North America Retinal Biologics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Retinal Biologics Market Size (2015-2020)
7.2 Retinal Biologics Key Players in Europe (2019-2020)
7.3 Europe Retinal Biologics Market Size by Type (2015-2020)
7.4 Europe Retinal Biologics Market Size by Application (2015-2020)
8 CHINA
8.1 China Retinal Biologics Market Size (2015-2020)
8.2 Retinal Biologics Key Players in China (2019-2020)
8.3 China Retinal Biologics Market Size by Type (2015-2020)
8.4 China Retinal Biologics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Retinal Biologics Market Size (2015-2020)
9.2 Retinal Biologics Key Players in Japan (2019-2020)
9.3 Japan Retinal Biologics Market Size by Type (2015-2020)
9.4 Japan Retinal Biologics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Retinal Biologics Market Size (2015-2020)
10.2 Retinal Biologics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinal Biologics Market Size by Type (2015-2020)
10.4 Southeast Asia Retinal Biologics Market Size by Application (2015-2020)
11 INDIA
11.1 India Retinal Biologics Market Size (2015-2020)
11.2 Retinal Biologics Key Players in India (2019-2020)
11.3 India Retinal Biologics Market Size by Type (2015-2020)
11.4 India Retinal Biologics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Retinal Biologics Market Size (2015-2020)
12.2 Retinal Biologics Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinal Biologics Market Size by Type (2015-2020)
12.4 Central & South America Retinal Biologics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Spark Therapeutics, Inc
13.1.1 Spark Therapeutics, Inc Company Details
13.1.2 Spark Therapeutics, Inc Business Overview and Its Total Revenue
13.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
13.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2015-2020))
13.1.5 Spark Therapeutics, Inc Recent Development
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Details
13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
13.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Regeneron Pharmaceuticals, Inc
13.3.1 Regeneron Pharmaceuticals, Inc Company Details
13.3.2 Regeneron Pharmaceuticals, Inc Business Overview and Its Total Revenue
13.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
13.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2015-2020)
13.3.5 Regeneron Pharmaceuticals, Inc Recent Development
13.4 AbbVie Inc
13.4.1 AbbVie Inc Company Details
13.4.2 AbbVie Inc Business Overview and Its Total Revenue
13.4.3 AbbVie Inc Retinal Biologics Introduction
13.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2015-2020)
13.4.5 AbbVie Inc Recent Development
13.5 Johnson & Johnson Services, Inc
13.5.1 Johnson & Johnson Services, Inc Company Details
13.5.2 Johnson & Johnson Services, Inc Business Overview and Its Total Revenue
13.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
13.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2015-2020)
13.5.5 Johnson & Johnson Services, Inc Recent Development
13.6 Amgen Inc
13.6.1 Amgen Inc Company Details
13.6.2 Amgen Inc Business Overview and Its Total Revenue
13.6.3 Amgen Inc Retinal Biologics Introduction
13.6.4 Amgen Inc Revenue in Retinal Biologics Business (2015-2020)
13.6.5 Amgen Inc Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Retinal Biologics Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Biologics Revenue
Table 3. Ranking of Global Top Retinal Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Macular Degeneration
Table 6. Key Players of Diabetic Retinopathy
Table 7. Key Players of Diabetic Macular Edema
Table 8. Key Players of Uveitis
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Retinal Biologics Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Retinal Biologics Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Retinal Biologics Players to Combat Covid-19 Impact
Table 15. Global Retinal Biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Retinal Biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Retinal Biologics Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Retinal Biologics Market Share by Regions (2015-2020)
Table 19. Global Retinal Biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Retinal Biologics Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Retinal Biologics Market Growth Strategy
Table 25. Main Points Interviewed from Key Retinal Biologics Players
Table 26. Global Retinal Biologics Revenue by Players (2015-2020) (Million US$)
Table 27. Global Retinal Biologics Market Share by Players (2015-2020)
Table 28. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2019)
Table 29. Global Retinal Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Retinal Biologics Product Solution and Service
Table 32. Date of Enter into Retinal Biologics Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 35. Global Retinal Biologics Market Size Share by Type (2015-2020)
Table 36. Global Retinal Biologics Revenue Market Share by Type (2021-2026)
Table 37. Global Retinal Biologics Market Size Share by Application (2015-2020)
Table 38. Global Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 39. Global Retinal Biologics Market Size Share by Application (2021-2026)
Table 40. North America Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Retinal Biologics Market Share (2019-2020)
Table 42. North America Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 43. North America Retinal Biologics Market Share by Type (2015-2020)
Table 44. North America Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 45. North America Retinal Biologics Market Share by Application (2015-2020)
Table 46. Europe Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Retinal Biologics Market Share (2019-2020)
Table 48. Europe Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Retinal Biologics Market Share by Type (2015-2020)
Table 50. Europe Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Retinal Biologics Market Share by Application (2015-2020)
Table 52. China Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 53. China Key Players Retinal Biologics Market Share (2019-2020)
Table 54. China Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 55. China Retinal Biologics Market Share by Type (2015-2020)
Table 56. China Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 57. China Retinal Biologics Market Share by Application (2015-2020)
Table 58. Japan Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Retinal Biologics Market Share (2019-2020)
Table 60. Japan Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Retinal Biologics Market Share by Type (2015-2020)
Table 62. Japan Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Retinal Biologics Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Retinal Biologics Market Share (2019-2020)
Table 66. Southeast Asia Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Retinal Biologics Market Share by Type (2015-2020)
Table 68. Southeast Asia Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Retinal Biologics Market Share by Application (2015-2020)
Table 70. India Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 71. India Key Players Retinal Biologics Market Share (2019-2020)
Table 72. India Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 73. India Retinal Biologics Market Share by Type (2015-2020)
Table 74. India Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 75. India Retinal Biologics Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Retinal Biologics Market Share (2019-2020)
Table 78. Central & South America Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Retinal Biologics Market Share by Type (2015-2020)
Table 80. Central & South America Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Retinal Biologics Market Share by Application (2015-2020)
Table 82. Spark Therapeutics, Inc Company Details
Table 83. Spark Therapeutics, Inc Business Overview
Table 84. Spark Therapeutics, Inc Product
Table 85. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 86. Spark Therapeutics, Inc Recent Development
Table 87. F. Hoffmann-La Roche Ltd Company Details
Table 88. F. Hoffmann-La Roche Ltd Business Overview
Table 89. F. Hoffmann-La Roche Ltd Product
Table 90. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 91. F. Hoffmann-La Roche Ltd Recent Development
Table 92. Regeneron Pharmaceuticals, Inc Company Details
Table 93. Regeneron Pharmaceuticals, Inc Business Overview
Table 94. Regeneron Pharmaceuticals, Inc Product
Table 95. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 96. Regeneron Pharmaceuticals, Inc Recent Development
Table 97. AbbVie Inc Company Details
Table 98. AbbVie Inc Business Overview
Table 99. AbbVie Inc Product
Table 100. AbbVie Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 101. AbbVie Inc Recent Development
Table 102. Johnson & Johnson Services, Inc Company Details
Table 103. Johnson & Johnson Services, Inc Business Overview
Table 104. Johnson & Johnson Services, Inc Product
Table 105. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 106. Johnson & Johnson Services, Inc Recent Development
Table 107. Amgen Inc Company Details
Table 108. Amgen Inc Business Overview
Table 109. Amgen Inc Product
Table 110. Amgen Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 111. Amgen Inc Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 1. Retinal Biologics Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Biologics Revenue
Table 3. Ranking of Global Top Retinal Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Macular Degeneration
Table 6. Key Players of Diabetic Retinopathy
Table 7. Key Players of Diabetic Macular Edema
Table 8. Key Players of Uveitis
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Retinal Biologics Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Retinal Biologics Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Retinal Biologics Players to Combat Covid-19 Impact
Table 15. Global Retinal Biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Retinal Biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Retinal Biologics Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Retinal Biologics Market Share by Regions (2015-2020)
Table 19. Global Retinal Biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Retinal Biologics Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Retinal Biologics Market Growth Strategy
Table 25. Main Points Interviewed from Key Retinal Biologics Players
Table 26. Global Retinal Biologics Revenue by Players (2015-2020) (Million US$)
Table 27. Global Retinal Biologics Market Share by Players (2015-2020)
Table 28. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2019)
Table 29. Global Retinal Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Retinal Biologics Product Solution and Service
Table 32. Date of Enter into Retinal Biologics Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 35. Global Retinal Biologics Market Size Share by Type (2015-2020)
Table 36. Global Retinal Biologics Revenue Market Share by Type (2021-2026)
Table 37. Global Retinal Biologics Market Size Share by Application (2015-2020)
Table 38. Global Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 39. Global Retinal Biologics Market Size Share by Application (2021-2026)
Table 40. North America Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Retinal Biologics Market Share (2019-2020)
Table 42. North America Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 43. North America Retinal Biologics Market Share by Type (2015-2020)
Table 44. North America Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 45. North America Retinal Biologics Market Share by Application (2015-2020)
Table 46. Europe Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Retinal Biologics Market Share (2019-2020)
Table 48. Europe Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Retinal Biologics Market Share by Type (2015-2020)
Table 50. Europe Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Retinal Biologics Market Share by Application (2015-2020)
Table 52. China Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 53. China Key Players Retinal Biologics Market Share (2019-2020)
Table 54. China Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 55. China Retinal Biologics Market Share by Type (2015-2020)
Table 56. China Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 57. China Retinal Biologics Market Share by Application (2015-2020)
Table 58. Japan Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Retinal Biologics Market Share (2019-2020)
Table 60. Japan Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Retinal Biologics Market Share by Type (2015-2020)
Table 62. Japan Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Retinal Biologics Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Retinal Biologics Market Share (2019-2020)
Table 66. Southeast Asia Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Retinal Biologics Market Share by Type (2015-2020)
Table 68. Southeast Asia Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Retinal Biologics Market Share by Application (2015-2020)
Table 70. India Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 71. India Key Players Retinal Biologics Market Share (2019-2020)
Table 72. India Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 73. India Retinal Biologics Market Share by Type (2015-2020)
Table 74. India Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 75. India Retinal Biologics Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Retinal Biologics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Retinal Biologics Market Share (2019-2020)
Table 78. Central & South America Retinal Biologics Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Retinal Biologics Market Share by Type (2015-2020)
Table 80. Central & South America Retinal Biologics Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Retinal Biologics Market Share by Application (2015-2020)
Table 82. Spark Therapeutics, Inc Company Details
Table 83. Spark Therapeutics, Inc Business Overview
Table 84. Spark Therapeutics, Inc Product
Table 85. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 86. Spark Therapeutics, Inc Recent Development
Table 87. F. Hoffmann-La Roche Ltd Company Details
Table 88. F. Hoffmann-La Roche Ltd Business Overview
Table 89. F. Hoffmann-La Roche Ltd Product
Table 90. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 91. F. Hoffmann-La Roche Ltd Recent Development
Table 92. Regeneron Pharmaceuticals, Inc Company Details
Table 93. Regeneron Pharmaceuticals, Inc Business Overview
Table 94. Regeneron Pharmaceuticals, Inc Product
Table 95. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 96. Regeneron Pharmaceuticals, Inc Recent Development
Table 97. AbbVie Inc Company Details
Table 98. AbbVie Inc Business Overview
Table 99. AbbVie Inc Product
Table 100. AbbVie Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 101. AbbVie Inc Recent Development
Table 102. Johnson & Johnson Services, Inc Company Details
Table 103. Johnson & Johnson Services, Inc Business Overview
Table 104. Johnson & Johnson Services, Inc Product
Table 105. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 106. Johnson & Johnson Services, Inc Recent Development
Table 107. Amgen Inc Company Details
Table 108. Amgen Inc Business Overview
Table 109. Amgen Inc Product
Table 110. Amgen Inc Revenue in Retinal Biologics Business (2015-2020) (Million US$)
Table 111. Amgen Inc Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Retinal Biologics Market Share by Type: 2020 VS 2026
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Diabetic Macular Edema Features
Figure 5. Uveitis Features
Figure 6. Others Features
Figure 7. Global Retinal Biologics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Retinal Biologics Report Years Considered
Figure 12. Global Retinal Biologics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Retinal Biologics Market Share by Regions: 2020 VS 2026
Figure 14. Global Retinal Biologics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Retinal Biologics Market Share by Players in 2019
Figure 17. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2019
Figure 19. North America Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Spark Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 28. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 30. Regeneron Pharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 32. AbbVie Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 34. Johnson & Johnson Services, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 36. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Figure 1. Global Retinal Biologics Market Share by Type: 2020 VS 2026
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Diabetic Macular Edema Features
Figure 5. Uveitis Features
Figure 6. Others Features
Figure 7. Global Retinal Biologics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Retinal Biologics Report Years Considered
Figure 12. Global Retinal Biologics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Retinal Biologics Market Share by Regions: 2020 VS 2026
Figure 14. Global Retinal Biologics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Retinal Biologics Market Share by Players in 2019
Figure 17. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2019
Figure 19. North America Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Retinal Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Spark Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 28. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 30. Regeneron Pharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 32. AbbVie Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 34. Johnson & Johnson Services, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 36. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
